Skip to main content

Table 2 Growth inhibitory effects of HepG2 human liver cancer cells by resveratrol and paclitaxel by an MTT

From: Resveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cells

Treatment

OD570 value

Inhibitory rate (%)

Control

0.431 ± 0.003a

/

PA-L

0.322 ± 0.006b

25.3 ± 2.1d

Res + PA-L

0.287 ± 0.008c

33.4 ± 2.2c

PA-H

0.202 ± 0.008d

53.1 ± 2.3b

Res + PA-H

0.089 ± 0.005e

79.4 ± 1.9a

  1. PA-L 5 μg/mL of paclitaxel, Res + PA-L 10 μg/mL of resveratrol +5 μg/mL of paclitaxel, PA-H 10 μg/mL of paclitaxel, Res + PA-H 10 μg/mL of resveratrol +10 μg/mL of paclitaxel
  2. a-eMean values with different letters in the same column are significantly different (P < 0.05) according to Dunnett’s post-hoc test
Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us